Tag: monoclonal antibody

Dupixent

FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...

Three-quarters of patients receiving Dupixent achieved at least a 75% improvement in overall disease, with an average improvement of approximately 80%.
Aimmune + Xencor

Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...

“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

The technique could also be applied to other IgE-mediated food allergies.

FARE Announces Grant for Promising Research

FARE has announced that it is providing over $700,000 to help fund promising research that may lead to a fast, effective treatment for food allergies.